David Hess
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David Hess has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey D. Klausner
From the *Department of Biology, Santa Clara University, Santa Clara, California; †Harvard School of Public Health, Boston, MA; ‡San Francisco Department of Public Health Labs, San Francisco, CA; §Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA
2 shared publicationsMark Pandori
From the *Department of Biology, Santa Clara University, Santa Clara, California; †Harvard School of Public Health, Boston, MA; ‡San Francisco Department of Public Health Labs, San Francisco, CA; §Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA
2 shared publicationsAbel Wu
San Francisco Public Health Laboratory, San Francisco, California, USA
1 shared publicationAlexandria Bs Shearer
From the *Department of Biology, Santa Clara University, Santa Clara, California; †Harvard School of Public Health, Boston, MA; ‡San Francisco Department of Public Health Labs, San Francisco, CA; §Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA
1 shared publication- Amy A. Caudy
Maple Flavored Solutions
1 shared publication - Balázs Papp
Synthetic and Systems Biology Unit, Institute of Biochemistry, National Laboratory of Biotechnology, HUN-REN Biological Research Centre , Temesvári Krt. 62, Szeged 6726
1 shared publication
Latest Publications
- 1 February 2015
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 42 (2) , 57-63
Fluoroquinolone Resistance in Neisseria gonorrhoeae After Cessation of Ciprofloxacin Usage in San Francisco
Background Ciprofloxacin resistance (CipR) among gonococcal strains in San Francisco (SF) increased between 2001 and 2006 and decreased between 2007 and 2009. Molecular typing of isolates obtained from 2005 to 2009 was performed to elucidate changes in CipR prevalence. Methods A total of 2526 samples were collected at the SF City Clinic between 2001 and 2009. Minimum inhibitory concentrations to ciprofloxacin were obtained by agar dilution. Prevalences of CipR strains were determined, with corresponding confidence intervals (CIs). Between 2005 and 2009, 460 isolates were selected for molecular typing using Neisseria gonorrhoeae multiantigen sequence typing. Results Between 2001 and 2006, the prevalence of CipR increased from 3.4% (95% CI, 1.3%–5.4%) to 44% (95% CI, 39%–50%). However, in 2007 prevalence began to decrease, reaching 9.6% (95% CI, 6.0%–13%) by 2009. Of the 203 strain types identified between 2005 and 2009, 126 genogroups of closely related strain types were formed (varying by ≤1% at both target loci). Levels of CipR within the data set correlate with the prevalence of 3 major genogroups (G): G437, G1407, and G3112. Conclusions Molecular typing reveals that CipR within the tested population is maintained by strain turnover between resistant genogroups. Despite early recommendation in 2002 to stop ciprofloxacin use in California, CipR in SF increased through 2006. The subsequent decrease in CipR corresponds with the 2007 national recommendation to cease ciprofloxacin treatment of gonorrhea, which suggests that national recommendations are potentially more effective at reducing CipR than regional recommendations in areas with high strain turnover.
- 1 February 2015
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 42 (2) , 57-63
Fluoroquinolone Resistance in Neisseria gonorrhoeae After Cessation of Ciprofloxacin Usage in San Francisco
Background Ciprofloxacin resistance (CipR) among gonococcal strains in San Francisco (SF) increased between 2001 and 2006 and decreased between 2007 and 2009. Molecular typing of isolates obtained from 2005 to 2009 was performed to elucidate changes in CipR prevalence. Methods A total of 2526 samples were collected at the SF City Clinic between 2001 and 2009. Minimum inhibitory concentrations to ciprofloxacin were obtained by agar dilution. Prevalences of CipR strains were determined, with corresponding confidence intervals (CIs). Between 2005 and 2009, 460 isolates were selected for molecular typing using Neisseria gonorrhoeae multiantigen sequence typing. Results Between 2001 and 2006, the prevalence of CipR increased from 3.4% (95% CI, 1.3%–5.4%) to 44% (95% CI, 39%–50%). However, in 2007 prevalence began to decrease, reaching 9.6% (95% CI, 6.0%–13%) by 2009. Of the 203 strain types identified between 2005 and 2009, 126 genogroups of closely related strain types were formed (varying by ≤1% at both target loci). Levels of CipR within the data set correlate with the prevalence of 3 major genogroups (G): G437, G1407, and G3112. Conclusions Molecular typing reveals that CipR within the tested population is maintained by strain turnover between resistant genogroups. Despite early recommendation in 2002 to stop ciprofloxacin use in California, CipR in SF increased through 2006. The subsequent decrease in CipR corresponds with the 2007 national recommendation to cease ciprofloxacin treatment of gonorrhea, which suggests that national recommendations are potentially more effective at reducing CipR than regional recommendations in areas with high strain turnover.
- Open Access
- 10 April 2014
- Published by Springer Nature in Genome Biology
- Vol. 15 (4) , R64
Broad metabolic sensitivity profiling of a prototrophic yeast deletion collection
Background: Genome-wide sensitivity screens in yeast have been immensely popular following the construction of a collection of deletion mutants of non-essential genes. However, the auxotrophic markers in this collection preclude experiments on minimal growth medium, one of the most informative metabolic environments. Here we present quantitative growth analysis for mutants in all 4,772 non-essential genes from our prototrophic deletion collection across a large set of metabolic conditions. Results: The complete collection was grown in environments consisting of one of four possible carbon sources paired with one of seven nitrogen sources, for a total of 28 different well-defined metabolic environments. The relative contributions to mutants' fitness of each carbon and nitrogen source were determined using multivariate statistical methods. The mutant profiling recovered known and novel genes specific to the processing of nutrients and accurately predicted functional relationships, especially for metabolic functions. A benchmark of genome-scale metabolic network modeling is also given to demonstrate the level of agreement between current in silico predictions and hitherto unavailable experimental data. Conclusions: These data address a fundamental deficiency in our understanding of the model eukaryote Saccharomyces cerevisiae and its response to the most basic of environments. While choice of carbon source has the greatest impact on cell growth, specific effects due to nitrogen source and interactions between the nutrients are frequent. We demonstrate utility in characterizing genes of unknown function and illustrate how these data can be integrated with other whole-genome screens to interpret similarities between seemingly diverse perturbation types.
- 10 April 2014
- Published by Springer Nature in Genome Biology
- Vol. 15 (4) , R64
Open AccessBroad metabolic sensitivity profiling of a prototrophic yeast deletion collection
Background: Genome-wide sensitivity screens in yeast have been immensely popular following the construction of a collection of deletion mutants of non-essential genes. However, the auxotrophic markers in this collection preclude experiments on minimal growth medium, one of the most informative metabolic environments. Here we present quantitative growth analysis for mutants in all 4,772 non-essential genes from our prototrophic deletion collection across a large set of metabolic conditions. Results: The complete collection was grown in environments consisting of one of four possible carbon sources paired with one of seven nitrogen sources, for a total of 28 different well-defined metabolic environments. The relative contributions to mutants' fitness of each carbon and nitrogen source were determined using multivariate statistical methods. The mutant profiling recovered known and novel genes specific to the processing of nutrients and accurately predicted functional relationships, especially for metabolic functions. A benchmark of genome-scale metabolic network modeling is also given to demonstrate the level of agreement between current in silico predictions and hitherto unavailable experimental data. Conclusions: These data address a fundamental deficiency in our understanding of the model eukaryote Saccharomyces cerevisiae and its response to the most basic of environments. While choice of carbon source has the greatest impact on cell growth, specific effects due to nitrogen source and interactions between the nutrients are frequent. We demonstrate utility in characterizing genes of unknown function and illustrate how these data can be integrated with other whole-genome screens to interpret similarities between seemingly diverse perturbation types.
- 1 November 2012
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (11) , 5633-5641
Genome Sequencing of a Neisseria gonorrhoeae Isolate of a Successful International Clone with Decreased Susceptibility and Resistance to Extended-Spectrum Cephalosporins
The recent emergence ofNeisseria gonorrhoeaestrains with decreased susceptibility to extended-spectrum cephalosporins is a major concern globally. We sequenced the genome of anN. gonorrhoeaemultiantigen sequence typing (NG-MAST) ST1407 isolate (SM-3) with decreased susceptibility and resistance to oral extended-spectrum cephalosporins. The isolate was cultured in 2008 in San Francisco, CA, and possessed mosaicpenAallele XXXIV, which is associated with an international clone that possesses decreased susceptibility as well as resistance to oral extended-spectrum cephalosporins globally. The genome sequence of strain NCCP11945 was used as a scaffold, and our assembly resulted in 91 contigs covering 2,029,064 bp (91%; >150× coverage) of the genome. Numerous instances of suspected horizontal genetic transfer events with otherNeisseriaspecies were identified, and two genes,opaandtxf, acquired from nongonococcalNeisseriaspecies, were identified. Strains possessing mosaicpenAalleles (n= 108) and nonmosaicpenAalleles (n= 169) from the United States and Europe (15 countries), cultured in 2002 to 2009, were screened for the presence of these genes. Theopagene was detected in most (82%)penAmosaic-containing isolates (mainly from 2007 to 2009) but not in anypenAnonmosaic isolates. Thetxfgene was found in all strains containingopabut also in several (18%)penAnonmosaic strains. Usingopaandtxfas genetic markers, we identified a strain that possesses mosaicpenAallele XXXIV, but the majority of its genome is not genetically related to strain SM-3. This implies thatpenAmosaic allele XXXIV was transferred horizontally. Such isolates also possessed decreased susceptibility and resistance to oral extended-spectrum cephalosporins. These findings support that genetic screening for particularpenAmosaic alleles can be a valuable method for tracking strains with decreased susceptibility as well as resistance to oral extended-spectrum cephalosporins worldwide and that screening using only NG-MAST may not be sufficient.
- 1 November 2012
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (11) , 5633-5641
Genome Sequencing of a Neisseria gonorrhoeae Isolate of a Successful International Clone with Decreased Susceptibility and Resistance to Extended-Spectrum Cephalosporins
The recent emergence ofNeisseria gonorrhoeaestrains with decreased susceptibility to extended-spectrum cephalosporins is a major concern globally. We sequenced the genome of anN. gonorrhoeaemultiantigen sequence typing (NG-MAST) ST1407 isolate (SM-3) with decreased susceptibility and resistance to oral extended-spectrum cephalosporins. The isolate was cultured in 2008 in San Francisco, CA, and possessed mosaicpenAallele XXXIV, which is associated with an international clone that possesses decreased susceptibility as well as resistance to oral extended-spectrum cephalosporins globally. The genome sequence of strain NCCP11945 was used as a scaffold, and our assembly resulted in 91 contigs covering 2,029,064 bp (91%; >150× coverage) of the genome. Numerous instances of suspected horizontal genetic transfer events with otherNeisseriaspecies were identified, and two genes,opaandtxf, acquired from nongonococcalNeisseriaspecies, were identified. Strains possessing mosaicpenAalleles (n= 108) and nonmosaicpenAalleles (n= 169) from the United States and Europe (15 countries), cultured in 2002 to 2009, were screened for the presence of these genes. Theopagene was detected in most (82%)penAmosaic-containing isolates (mainly from 2007 to 2009) but not in anypenAnonmosaic isolates. Thetxfgene was found in all strains containingopabut also in several (18%)penAnonmosaic strains. Usingopaandtxfas genetic markers, we identified a strain that possesses mosaicpenAallele XXXIV, but the majority of its genome is not genetically related to strain SM-3. This implies thatpenAmosaic allele XXXIV was transferred horizontally. Such isolates also possessed decreased susceptibility and resistance to oral extended-spectrum cephalosporins. These findings support that genetic screening for particularpenAmosaic alleles can be a valuable method for tracking strains with decreased susceptibility as well as resistance to oral extended-spectrum cephalosporins worldwide and that screening using only NG-MAST may not be sufficient.